Companies 0 See All

Hedge Funds 0 See All

Insiders 0 See All

Institutional Investors 0 See All

Click here to see all results for

Home > Insider Trading > Filing (0001019687-10-003474)

Filing Details

Accession Number:: 0001019687-10-003474
Form Type:: 4
Zero Holdings:: No
Publication Time:: 2010-09-27 13:40:22
Reporting Period:: 2010-09-24

Filing Date:: 2010-09-27
Accepted Time:: 2010-09-27 13:40:22
SEC Url:: Form 4 Filing

Issuer

Cik	Name	Symbol	Sector (SIC)	IRS No
704562	Peregrine Pharmaceuticals Inc	PPHM	In Vitro & In Vivo Diagnostic Substances (2835)	953698422

Insiders

Cik	Name	Reported Address	Insider Title	Director	Officer	Large Shareholder	Other
1244110	J Paul Lytle	C/O Peregrine Pharmaceuticals, Inc. 14282 Franklin Avenue Tustin, CA 92780	Chief Financial Officer	No	Yes	No	No

Reported Non-Derivative Transactions

Show Other Fields >>

Sec. Name	Acquisiton - Disposition	Date	Amount	Price	Remaning Holdings	Equity Swap Involved	Form Type	Code	Nature of Ownership	Explanation
Common Stock, $0.001 Par Value	Acquisiton	2010-09-24	6,684	$1.34	72,051	No	4	P	Direct

Equity Swap Involved	Form Type	Code	Nature of Ownership	Explanation
No	4	P	Direct

Reported Derivative Holdings

Show Other Fields >>

Sec. Name	Sec. Type	Price	Date	Expiration Date	Amount	Remaning Holdings	Nature of Ownership
Common Stock	Incentive Stock Option (right to buy)	$0.00			0	237,000	Direct

Expiration Date	Amount	Remaning Holdings	Nature of Ownership
	0	237,000	Direct

Footnotes

Includes performance-based restricted shares issued pursuant to a Stock Issuance Agreement dated February 1, 2010.
Not applicable.